Syn Bio Companies Put the Earth into Focus
While some synthetic biology companies are using biology to improve our food, clothes, and medicine, others are turning their attention to helping the Earth.
Demystifying Synthetic Biology: Building with the power of biology
Technology today is defined by superlatives: we have the fastest cars, the best medicine, and the most advanced communication tools ever known. Yet despite humanity’s technological progress…
Antheia Appoints Heidi Pucel as Chief People Officer
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced the appointment of Heidi Pucel as its Chief People Officer. Pucel joins the company as it prepares to significantly increase…
Seven Biopharma Trends to Watch in 2022
Synthetic biology attracted $8.9 billion in venture funding during the first half of 2021, according to synbio stakeholder group SynBioBeta, and launched two successful initial public offerings: Zymergen’s $529.6 million traditional IPO and Ginkgo Bioworks…
Dr. Christina Smolke of Antheia On The 5 Leadership Lessons She Learned From Her Experience
As a part of my series about “Lessons From Inspirational Women in STEM and Tech”, I had the pleasure of interviewing Christina Smolke…
Introducing Zack McGahey, Antheia’s COO
Antheia is at a critical point in scaling our production technology. Just as we bring together exceptional science and technologies to unleash the power of plants to inspire the next generation of medicines…
Can Synthetic Biology Save Us? This Scientist Thinks So.
Drew Endy is squarely focused on the potential of redesigning organisms for useful purposes. He also acknowledges significant challenges…
BioSpace Movers & Shakers, Nov. 19
Zack McGahey was named COO and will be responsible for all operations functions as the company scales and commercializes its first products. Prior to joining Antheia, McGahey served as vice president of manufacturing…
Antheia Appoints Zack McGahey as Chief Operating Officer
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced the appointment of Zack McGahey as Chief Operating Officer…
Making Drugs From Yeast
Antheia CEO Christina Smolke brews up new pharmaceuticals…
